Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2984418rdf:typepubmed:Citationlld:pubmed
pubmed-article:2984418lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:2984418lifeskim:mentionsumls-concept:C0002007lld:lifeskim
pubmed-article:2984418lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2984418lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:2984418lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:2984418lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:2984418lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:2984418pubmed:issue4lld:pubmed
pubmed-article:2984418pubmed:dateCreated1985-5-10lld:pubmed
pubmed-article:2984418pubmed:abstractTextSeveral steroid derivatives having the 11 beta,18-epoxypregnane skeleton, 7, 8, 19, 20, 21, and 31, were synthesized to evaluate their antialdosterone activity. Among them, 3-(9 alpha-fluoro-17 beta-hydroxy-3-oxoandrost-4-en-17 alpha-yl)propionic acid gamma-lactone (31) possessed fairly strong binding affinity for the cytoplasmic mineralocorticoid receptor of rat kidney and exhibited good aldosterone antagonist activity in an in vivo assay. However, its agonistic nature cannot be ignored. The properties of 31 as an aldosterone antagonist were enhanced by its very low to negligible binding affinity for the androgen, progestin, estrogen, and glucocorticoid receptors.lld:pubmed
pubmed-article:2984418pubmed:languageenglld:pubmed
pubmed-article:2984418pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984418pubmed:citationSubsetIMlld:pubmed
pubmed-article:2984418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984418pubmed:statusMEDLINElld:pubmed
pubmed-article:2984418pubmed:monthAprlld:pubmed
pubmed-article:2984418pubmed:issn0022-2623lld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:ShimizuTTlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:NakamuraMMlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:KawabataTTlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:MiyataKKlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:KondoEElld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:KamataSSlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:HageJJlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:OdaguchiKKlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:NagataWWlld:pubmed
pubmed-article:2984418pubmed:authorpubmed-author:MitsugiTTlld:pubmed
pubmed-article:2984418pubmed:issnTypePrintlld:pubmed
pubmed-article:2984418pubmed:volume28lld:pubmed
pubmed-article:2984418pubmed:ownerNLMlld:pubmed
pubmed-article:2984418pubmed:authorsCompleteNlld:pubmed
pubmed-article:2984418pubmed:pagination428-33lld:pubmed
pubmed-article:2984418pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:meshHeadingpubmed-meshheading:2984418-...lld:pubmed
pubmed-article:2984418pubmed:year1985lld:pubmed
pubmed-article:2984418pubmed:articleTitleAldosterone antagonists. 1. Synthesis and biological activities of 11 beta,18-epoxypregnane derivatives.lld:pubmed
pubmed-article:2984418pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2984418pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2984418lld:chembl